(MENAFN- GlobeNewsWire - Nasdaq) Key opportunities in the spinal cord stimulators market include catering to the rising chronic pain and neuropathy cases, advancements in rechargeable devices, and ...

Request To Download Free Sample of This Strategic Report @ Market Overview In 2018, the global neurostimulation devices market exhibited a valuation of $4,387.5 million, marking the inception of a ...

After selling RDN developer SoniVie to Boston Scientific for $600 million, Ray Cohen discusses competing devices from ...

Shares of Boston Scientific BSX have climbed 7% over the past 30 days, extending their positive year-to-date momentum. The stock’s performance has outpaced its industry’s 0.9% gains, the broader ...

Medtronic MDT is set to release second-quarter fiscal 2026 results on Nov. 18, before the market opens. The MedTech giant ...

Treating chronic neuropathic pain with spinal cord stimulation may help prevent excess mortality associated with chronic pain, a new study from the University of Eastern Finland and Kuopio University ...

SOLIS trial demonstrates that spinal cord stimulation (SCS) provides superior, sustained pain relief, function, and quality of life in nonsurgical refractory back pain.

Spinal cord injury (SCI) causes paralysis in roughly one million people worldwide, with incident cases rising yearly. Beyond motor and sensory deficits, patients frequently experience muscle atrophy, ...

Sixteen years after suffering a paralyzing spinal cord injury during his final football game at Highland High School, Kory Wiita has become an inspiration for others with similar debilitating ...

Oct 21 (Reuters) - Walmart (WMT.N), opens new tab will become the first U.S. retailer to sell Abbott Laboratories' (ABT.N), opens new tab over-the-counter continuous glucose monitor Lingo in physical ...

The global active implantable medical devices market is being driven by the increasing incidence of chronic diseases, such as cardiovascular, neurological, and hearing disorders, as well as ongoing ...